BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 15554891)

  • 1. New insights in the genetics of isolated hypogonadotropic hypogonadism.
    Iovane A; Aumas C; de Roux N
    Eur J Endocrinol; 2004 Nov; 151 Suppl 3():U83-8. PubMed ID: 15554891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular genetics of isolated hypogonadotropic hypogonadism and Kallmann syndrome.
    Karges B; Roux N
    Endocr Dev; 2005; 8():67-80. PubMed ID: 15722618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [GnRH deficiency: new insights from genetics].
    Kottler ML; Hamel A; Malville E; Richard N
    J Soc Biol; 2004; 198(1):80-7. PubMed ID: 15146960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolated gonadotropic deficiency with and without anosmia: a developmental defect or a neuroendocrine regulation abnormality of the gonadotropic axis.
    de Roux N
    Horm Res; 2005; 64 Suppl 2():48-55. PubMed ID: 16286771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Congenital hypogonadotropic hypogonadism in females: clinical spectrum, evaluation and genetics.
    Bry-Gauillard H; Trabado S; Bouligand J; Sarfati J; Francou B; Salenave S; Chanson P; Brailly-Tabard S; Guiochon-Mantel A; Young J
    Ann Endocrinol (Paris); 2010 May; 71(3):158-62. PubMed ID: 20363464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic insights into human isolated gonadotropin deficiency.
    Trarbach EB; Silveira LG; Latronico AC
    Pituitary; 2007; 10(4):381-91. PubMed ID: 17624596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The GPR54 gene as a regulator of puberty.
    Seminara SB; Messager S; Chatzidaki EE; Thresher RR; Acierno JS; Shagoury JK; Bo-Abbas Y; Kuohung W; Schwinof KM; Hendrick AG; Zahn D; Dixon J; Kaiser UB; Slaugenhaupt SA; Gusella JF; O'Rahilly S; Carlton MB; Crowley WF; Aparicio SA; Colledge WH
    N Engl J Med; 2003 Oct; 349(17):1614-27. PubMed ID: 14573733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GnRH receptor and GPR54 inactivation in isolated gonadotropic deficiency.
    de Roux N
    Best Pract Res Clin Endocrinol Metab; 2006 Dec; 20(4):515-28. PubMed ID: 17161329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in fibroblast growth factor receptor 1 cause both Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism.
    Pitteloud N; Acierno JS; Meysing A; Eliseenkova AV; Ma J; Ibrahimi OA; Metzger DL; Hayes FJ; Dwyer AA; Hughes VA; Yialamas M; Hall JE; Grant E; Mohammadi M; Crowley WF
    Proc Natl Acad Sci U S A; 2006 Apr; 103(16):6281-6. PubMed ID: 16606836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hypogonadotropic hypogonadism: new aspects in the regulation of hypothalamic-pituitary-gonadal axis].
    Brioude F; Bouvattier CE; Lombès M
    Ann Endocrinol (Paris); 2010 Sep; 71 Suppl 1():S33-41. PubMed ID: 21237329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypogonadotropic hypogonadism due to loss of function of the KiSS1-derived peptide receptor GPR54.
    de Roux N; Genin E; Carel JC; Matsuda F; Chaussain JL; Milgrom E
    Proc Natl Acad Sci U S A; 2003 Sep; 100(19):10972-6. PubMed ID: 12944565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversible kallmann syndrome, delayed puberty, and isolated anosmia occurring in a single family with a mutation in the fibroblast growth factor receptor 1 gene.
    Pitteloud N; Acierno JS; Meysing AU; Dwyer AA; Hayes FJ; Crowley WF
    J Clin Endocrinol Metab; 2005 Mar; 90(3):1317-22. PubMed ID: 15613419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel loss-of-function mutation in GPR54/KISS1R leads to hypogonadotropic hypogonadism in a highly consanguineous family.
    Nimri R; Lebenthal Y; Lazar L; Chevrier L; Phillip M; Bar M; Hernandez-Mora E; de Roux N; Gat-Yablonski G
    J Clin Endocrinol Metab; 2011 Mar; 96(3):E536-45. PubMed ID: 21193544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutation analyses in pedigrees and sporadic cases of ethnic Han Chinese Kallmann syndrome patients.
    Gu WJ; Zhang Q; Wang YQ; Yang GQ; Hong TP; Zhu DL; Yang JK; Ning G; Jin N; Chen K; Zang L; Wang AP; Du J; Wang XL; Yang LJ; Ba JM; Lv ZH; Dou JT; Mu YM
    Exp Biol Med (Maywood); 2015 Nov; 240(11):1480-9. PubMed ID: 26031747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [From gene to disease; hypogonatrophic hypogonadism and anosmia: Kallmann's syndrome].
    Voorhoeve PG; Delemarre-van de Waal HA
    Ned Tijdschr Geneeskd; 2004 Jun; 148(23):1142-4. PubMed ID: 15211964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroendocrine phenotype analysis in five patients with isolated hypogonadotropic hypogonadism due to a L102P inactivating mutation of GPR54.
    Tenenbaum-Rakover Y; Commenges-Ducos M; Iovane A; Aumas C; Admoni O; de Roux N
    J Clin Endocrinol Metab; 2007 Mar; 92(3):1137-44. PubMed ID: 17164310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical assessment and mutation analysis of Kallmann syndrome 1 (KAL1) and fibroblast growth factor receptor 1 (FGFR1, or KAL2) in five families and 18 sporadic patients.
    Sato N; Katsumata N; Kagami M; Hasegawa T; Hori N; Kawakita S; Minowada S; Shimotsuka A; Shishiba Y; Yokozawa M; Yasuda T; Nagasaki K; Hasegawa D; Hasegawa Y; Tachibana K; Naiki Y; Horikawa R; Tanaka T; Ogata T
    J Clin Endocrinol Metab; 2004 Mar; 89(3):1079-88. PubMed ID: 15001591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-syndromic congenital hypogonadotropic hypogonadism: clinical presentation and genotype-phenotype relationships.
    Brioude F; Bouligand J; Trabado S; Francou B; Salenave S; Kamenicky P; Brailly-Tabard S; Chanson P; Guiochon-Mantel A; Young J
    Eur J Endocrinol; 2010 May; 162(5):835-51. PubMed ID: 20207726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations in fibroblast growth factor receptor 1 cause Kallmann syndrome with a wide spectrum of reproductive phenotypes.
    Pitteloud N; Meysing A; Quinton R; Acierno JS; Dwyer AA; Plummer L; Fliers E; Boepple P; Hayes F; Seminara S; Hughes VA; Ma J; Bouloux P; Mohammadi M; Crowley WF
    Mol Cell Endocrinol; 2006 Jul; 254-255():60-9. PubMed ID: 16764984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Digenic mutations account for variable phenotypes in idiopathic hypogonadotropic hypogonadism.
    Pitteloud N; Quinton R; Pearce S; Raivio T; Acierno J; Dwyer A; Plummer L; Hughes V; Seminara S; Cheng YZ; Li WP; Maccoll G; Eliseenkova AV; Olsen SK; Ibrahimi OA; Hayes FJ; Boepple P; Hall JE; Bouloux P; Mohammadi M; Crowley W
    J Clin Invest; 2007 Feb; 117(2):457-63. PubMed ID: 17235395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.